PNW Connection

Back to Blog
Blog Teaser Image

Lucy’s Story - September Strong

Share:

 

“No child should have to endure what Lucy has endured,” said Nicole Watters, mother of 7-year-old cancer fighter Lucy.

On Christmas Eve 2014, Lucy’s parents knew she had pneumonia, but something else was wrong too, something much worse. At 11 p.m., they got the call. Their daughter was diagnosed with leukemia and they needed to take her to Seattle Children’s right away.  

After a transplant, a relapse meant that Lucy’s battle was far from over. She underwent, what Nicole describes as, “potent” chemotherapy and stayed at Seattle Children’s for 42 days during treatment. “I think in those 42 days she maybe got out of bed 10 times. She was really, really sick from the chemo,” said Nicole.

Instead of having Lucy endure a second transplant right away, her parents opted to enroll her in a T-cell immunotherapy clinical trial at Seattle Children’s. It was a tough fight that included a second transplant after the immunotherapy treatment in July 2017.

Unfortunately, Lucy relapsed again. She once again began chemotherapy treatment. This treatment plan put Lucy in remission until August of 2018, when her cancer returned for a third time. Lucy’s care team decided that PLAT-05, a new arm of our Pediatric Leukemia Adoptive Therapy trials, was her best option. Lucy’s T cells were re-engineered in October 2018 and she began the PLAT-05 trial protocol in January 2019. Cancer is tricky and Seattle Children’s researchers are racing to outsmart it for Lucy and so many other kids.

As a strong believer that immunotherapy should be a treatment option for more kids fighting cancer, Nicole says, “One reason to donate to Strong Against Cancer is so that we can continue this research and hopefully soon, have immunotherapy be a first line of defense instead of a last resort. Donate, so that in the future, kids like Lucy don’t have to go through chemo and radiation that cause so many lifelong problems and so all kids have a chance at a long and healthy life.”

Seattle Children’s Hospital and Research Foundation